Dow Up 0.07% Nasdaq Up 0.61%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.89 Up 0.06(0.38%) Nov 26, 4:00PM EST
|After Hours : 15.89 0.00 (0.00%) Nov 26, 4:36PM EST
Prev Close:15.83
Open:15.79
Bid:14.00 x 1000
Ask:N/A
1y Target Est:23.58
Beta:6.55
Next Earnings Date:N/A
Day's Range:15.74 - 15.95
52wk Range:11.53 - 18.48
Volume:398,537
Avg Vol (3m):2,348,920
Market Cap:1.46B
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 0.38%1.46B
BAXDown 0.06%39.24B
SHPGUp 1.15%42.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):141.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Dec-14) :-0.37
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback